Cited by 431Fibroblast Growth Factor ResearchMetabolism, Diabetes, and CancerPancreatic function and diabetes

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

FGF15/19 Regulates Hepatic Glucose Metabolism by Inhibiting the CREB-PGC-1α Pathway

Open access

Potthoff, Matthew J., Boney-Montoya, Jamie, Choi, Mihwa, He, Tianteng, Sunny, Nishanth E., Satapati, Santhosh, Suino-Powell, Kelly, Xu, H. Eric, Gerard, Robert D., Finck, Brian N., Burgess, Shawn C., Mangelsdorf, David J., Kliewer, Steven A.·2011·Cell Metabolism

DOI 10.1016/j.cmet.2011.03.019PMC PMC3131185

Open this paper in CoChat — free account Open PDF

Abstract

Regulation of hepatic carbohydrate homeostasis is crucial for maintaining energy balance in the face of fluctuating nutrient availability. Here, we show that the hormone fibroblast growth factor 15/19 (FGF15/19), which is released postprandially from the small intestine, inhibits hepatic gluconeogenesis, like insulin. However, unlike insulin, which peaks in serum 15 min after feeding, FGF15/19 expression peaks approximately 45 min later, when bile acid concentrations increase in the small intestine. FGF15/19 blocks the expression of genes involved in gluconeogenesis through a mechanism involving the dephosphorylation and inactivation of the transcription factor cAMP regulatory element-binding protein (CREB). This in turn blunts expression of peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) and other genes involved in hepatic metabolism. Overexpression of PGC-1α blocks the inhibitory effect of FGF15/19 on gluconeogenic gene expression. These results demonstrate that FGF15/19 works subsequent to insulin as a postprandial regulator of hepatic carbohydrate homeostasis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2011.03.019

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Transcriptional regulation by the phosphorylation-dependent factor CREB
Mayr, B., & Montminy, M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085068 · Cited by 2,587
Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133
Gonzalez, G. A., & Montminy, M. (1989) · Cell · doi:10.1016/0092-8674(89)90013-5 · Cited by 2,464
Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α (PGC-1α): Transcriptional Coactivator and Metabolic Regulator
Puigserver, P., & Spiegelman, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0012 · Cited by 2,076
Phosphorylated CREB binds specifically to the nuclear protein CBP
Chrivia, J. C., Kwok, R. P. S., Lamb, N., Hagiwara, M., Montminy, M. R., & Goodman, R. H. (1993) · Nature · doi:10.1038/365855a0 · Cited by 2,052
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Self-citation
Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Self-citation
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
Finck, B. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27794 · Cited by 1,461
Self-citation
Nuclear protein CBP is a coactivator for the transcription factor CREB
Kwok, R. P. S., Lundblad, J. R., Chrivia, J. C., Richards, J. P., Bächinger, H. P., Brennan, R. G., Roberts, S. G. E., Green, M. R., & Goodman, R. H. (1994) · Nature · doi:10.1038/370223a0 · Cited by 1,443
CREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440

Flagged first, then by citations

Show all 51 references

Sorted by citations

Items 301–400 of 428

Association of inflammatory cytokines with type 2 diabetes mellitus and diabetic nephropathy: a bidirectional Mendelian randomization study
Song, S., Ni, J., Sun, Y., Pu, Q., Zhang, L., Yan, Q., & Yu, J. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1459752 · Cited by 15
Bile Acids and Type 2 Diabetes: Roles in Glucose Homeostasis and Therapeutic Opportunities
Lin, Y., Hu, C., Wang, S., & Lin, H. (2025) · Metabolites · doi:10.3390/metabo15060401 · Cited by 9
Bile acids and gestational diabetes mellitus: exploring the link and implications - a review
Lu, C., Gao, Z., & Lei, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1574228 · Cited by 11
Intestinal BMP-9 locally upregulates FGF19 and is down-regulated in obese patients with diabetes
Drexler, S., Cai, C., Hartmann, A.-L., Moch, D., Gaitantzi, H., Ney, T., Kraemer, M., Chu, Y., Zheng, Y., Rahbari, M., et al. (2023) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2023.111934 · Cited by 8
A short report on NGM282/aldafermin for the treatment of nonalcoholic steatohepatitis (NASH)
Roberts, S. K., & Majeed, A. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1999416 · Cited by 8
Walker-256 Tumour-Induced Cachexia Altered Liver Metabolomic Profile and Function in Weanling and Adult Rats
Miyaguti, N. A. D. S., Chiocchetti, G. D. M. E., Salgado, C. D. M., Lopes‐Aguiar, L., Viana, L. R., Blanchard, L., dos Santos, R. W., & Gomes‐Marcondes, M. C. C. (2021) · Metabolites · doi:10.3390/metabo11120831 · Cited by 8
Primary Biliary Cholangitis: Promising Emerging Innovative Therapies and Their Impact on GLOBE Scores
Sohal, A., & Kowdley, K. V. (2023) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s361077 · Cited by 8
Modulation of Hepatic Protein Kinase Cβ Expression in Metabolic Adaptation to a Lithogenic Diet
Huang, W., & Mehta, K. D. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.05.008 · Cited by 8
Regulation of fibroblast growth factor 9 on the differentiation of goat intramuscular adipocytes
Huang, K., Wang, Y., Zhu, J., Xiong, Y., & Lin, Y. (2021) · Animal Science Journal · doi:10.1111/asj.13627 · Cited by 8
Targeting the Gut in Obesity: Signals from the Inner Surface
Petersen, N., Greiner, T. U., Torz, L., Bookout, A. L., Gerstenberg, M. K., Castorena, C. M., & Kuhre, R. E. (2022) · Metabolites · doi:10.3390/metabo12010039 · Cited by 8
Pathogenetic therapeutic approaches for endocrine diseases based on antisense oligonucleotides and RNA-interference
Golounina, O. O., Minniakhmetov, I. R., Ринатович, С. Р., Khusainova, R. I., Zakharova, E., Bychkov, I. O., & Mokrysheva, N. G. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1525373 · Cited by 8
Profile of the bile acid FXR-FGF15 pathway in the glucolipid metabolism disorder of diabetic mice suffering from chronic stress
Cai, W., Li, C., Su, Z., Cao, J., Chen, Z., Chen, Y., Guo, Z., Cai, J., & Xu, F. (2023) · PeerJ · doi:10.7717/peerj.16407 · Cited by 8
Ji-Ni-De-Xie ameliorates type 2 diabetes mellitus by modulating the bile acids metabolism and FXR/FGF15 signaling pathway
Tao, Y., Fang, P., Wang, L., Sun, J., Ding, Y., Xiong, S., Tenzin, U., MiMa, Nhamdriel, T., & Fan, G. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1383896 · Cited by 7
Polyguluronate sulfate and its oligosaccharides but not heparin promotes FGF19/FGFR1c signaling
Lan, Y., Zeng, X., Guo, Z., Zeng, P., Hao, C., Zhao, X., Yu, G., & Zhang, L. (2017) · Journal of Ocean University of China · doi:10.1007/s11802-017-3195-x · Cited by 7
Fexaramine as the intestine-specific farnesoid X receptor agonist: A promising agent to treat obesity and metabolic disorders
Dąbrowska, A. M., & Dudka, J. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104386 · Cited by 6
FGF19 Promotes the Proliferation and Insulin Secretion from Human Pancreatic β Cells Via the IRS1/GLUT4 Pathway
Zeng, T., Tang, X., Bai, X., & Xiong, H. (2024) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2250-7830 · Cited by 6
A primer on the pleiotropic endocrine fibroblast growth factor FGF19/FGF15
Bouju, A., Nusse, R., & Wu, P. V. (2024) · Differentiation · doi:10.1016/j.diff.2024.100816 · Cited by 7
Bridging cell surface receptor with nuclear receptors in control of bile acid homeostasis
Li, S., Ni, A., & Feng, G. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.118 · Cited by 6
Fibroblast growth factor 15, induced by elevated bile acids, mediates the improvement of hepatic glucose metabolism after sleeve gastrectomy
Wei, M., Cao, W.-B., Zhao, R.-D., Sun, D.-P., Liang, Y.-Z., Huang, Y., Cheng, Z.-W., Ouyang, J., Yang, W.-S., & Yu, W. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i21.3280 · Cited by 6
Vertical sleeve gastrectomy improves glucose-insulin homeostasis by enhancing β-cell function and survival via FGF15/19
Soares, G. M., Balbo, S. L., Bronczek, G. A., Vettorazzi, J. F., Marmentini, C., Zangerolamo, L., Velloso, L. A., & Carneiro, E. M. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00218.2023 · Cited by 5
Decreased serum fibroblast growth factor 19 level is a risk factor for type 1 diabetes
Hu, J., Tang, Y., Liu, H., Li, Y., Li, X., Huang, G., Xiao, Y., & Zhou, Z. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-5203 · Cited by 5
Sulfated Glycosaminoglycan-Assisted Receptor Specificity of Human Fibroblast Growth Factor (FGF) 19 Signaling in a Mouse System Is Different from That in a Human System
Nakamura, M., Uehara, Y., Asada, M., Suzuki, M., & Imamura, T. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112463820 · Cited by 6
Bile Acids as Signaling Molecules
Claudel, T., & Trauner, M. A. (2020) · Liver · doi:10.1002/9781119436812.ch25 · Cited by 6
Dysregulated bile acid metabolism drives lipid peroxidation and ferroptosis in NAFLD: therapeutic potential for traditional Chinese medicine
Liu, J., Li, F., Zeng, Q., Hu, W., Yang, L., Luo, S., Li, D., & Deng, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1669805 · Cited by 8
Metabolomics Signatures of Atherosclerosis in Cardiovascular Disease: A Narrative Systematic Review
Pibiri, M., Noto, A., Dalu, A., Muntoni, S., Kopeć, K. K., Spada, M., Atzori, L., & Piras, C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14228028 · Cited by 5
Age of Cafeteria Diet Onset Influences Obesity Phenotype in Mice in a Sex-Specific Manner
Bazhan, N., Kazantseva, A., Dubinina, A., Balybina, N. Y., Jakovleva, T., & Makarova, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212436 · Cited by 4
Changes in the intestinal expression of drug metabolism-related genes in a piglet model of parenteral nutrition
Dai, L., Zhao, Y., Jiang, L., & Yan, J. (2022) · Nutrition & Metabolism · doi:10.1186/s12986-022-00654-8 · Cited by 5
The role of fibroblast growth factor 19 in the pathogenesis of nonalcoholic fatty liver disease
Chrysavgis, L., Giannakodimos, I., Chatzigeorgiou, A., Τζιόμαλος, Κ., Papatheodoridis, G., & Cholongitas, Ε. (2022) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2022.2127408 · Cited by 5
Effects of Different Feed Additives on Intestinal Metabolite Composition of Weaned Piglets
Zhao, M., Zhang, J., Liu, F., Luo, L., Wei, M., Ye, Y., Chamba, Y., & Shang, P. (2024) · Metabolites · doi:10.3390/metabo14030138 · Cited by 5
Factors associated with fibroblast growth factor 19 increment after oral glucose loading in patients who were previously admitted for coronary angiography
Wang, J., Lee, C.-L., Lee, W., Lee, I., Lin, S., Lee, W.-L., Liang, K., & Sheu, W. H. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.09.006 · Cited by 5
13C Flux Analysis in Biotechnology and Medicine
Cheah, Y. E., Hasenour, C. M., & Young, J. D. (2017) · Systems Biology · doi:10.1002/9783527696130.ch2 · Cited by 5
Secreted proteins in treating metabolic dysfunction-associated steatotic liver disease: from bench towards bedside
Huang, Y., Liu, B., Hu, C., & Lu, Y. (2025) · Protein & Cell · doi:10.1093/procel/pwaf027 · Cited by 4
Gut Factors Mediating the Physiological Impact of Bariatric Surgery
Bethea, M. M., & Sandoval, D. A. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01478-9 · Cited by 4
The role of FGF19–FGFR4 signaling pathway in liver health and disease: Guardian or destroyer
Wu, Z., Wang, Y., Zhang, J., Li, S., Wen, J., Hu, D., Jiang, J., Zhang, Z., Luo, X., & Xia, L. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101989 · Cited by 3
Psammaplysene D overcomes sorafenib resistance in liver cancer by targeting FGFR4/CYP26A1-retinoic acid axis to drive ferroptosis
Yang, T., Han, Y., Wang, Y., Li, R.-Y., Zhang, X.-N., Zhang, X.-X., Xu, X., Xu, J., Li, X.-Y., Lin, C.-H., et al. (2026) · Journal of experimental & clinical cancer research : CR · doi:10.1186/s13046-025-03622-1 · Cited by 3
Size matters: the biochemical logic of ligand type in endocrine crosstalk
Lone, J. B., Long, J. Z., & Svensson, K. J. (2023) · Life Metabolism · doi:10.1093/lifemeta/load048 · Cited by 4
Circadian Regulation of Endocrine Fibroblast Growth Factors on Systemic Energy Metabolism
Yang, Z., Zarbl, H., & Guo, G. L. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.123.000831 · Cited by 3
Implications for Farnesoid X Receptor Signaling on Bile Acid Metabolism as a Potential Therapeutic Strategy for Nonalcoholic Fatty Liver Disease
Yang, H., & Park, C. (2016) · The Korean Journal of Obesity · doi:10.7570/kjo.2016.25.4.167 · Cited by 3
Role of FGF15 in Hepatic Surgery in the Presence of Tumorigenesis: Dr. Jekyll or Mr. Hyde?
Caballeria-Casals, A., Micó-Carnero, M., Rojano-Alfonso, C., Maroto-Serrat, C., Casillas-Ramírez, A., Álvarez‐Mercado, A. I., Gracia‐Sancho, J., & Peralta, C. (2021) · Cells · doi:10.3390/cells10061421 · Cited by 3
The Role of Bile Acid in Improving Glucose Tolerance of Non-Obese Diabetic Rats After Proximal Small Bowel Bypass
Zheng, Z., Pang, Q., Luo, X., Fang, T., Duan, J., & Cao, J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.878505 · Cited by 3
Effects of apical sodium-bile acid transporter inhibitor and obeticholic acid co-treatment in experimental non-alcoholic steatohepatitis
Matye, D. J., Qin, X., Hasan, M. N., Gu, L., Clayton, Y. D., Li, F., & Li, T. (2022) · Liver Research · doi:10.1016/j.livres.2022.11.002 · Cited by 3
Ingestion of whey protein and β-conglycinin exerts opposite effects on intestinal FGF15 and serotonin secretion in mice
Nonogaki, K., & Kaji, T. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1080790 · Cited by 3
Differences of serum glucose and lipid metabolism and immune parameters and blood metabolomics regarding the transition cows in the antepartum and postpartum period
Zhao, X., Wang, Y., Wang, L., Sun, S., Li, C., Zhang, X., Chen, L., & Tian, Y. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1347585 · Cited by 3
Bile acid sequestrant inhibits gluconeogenesis via inducing hepatic cysteine dioxygenase type 1 to reduce cysteine availability
Matye, D. J., Wang, H., Wang, Y., Xiong, L., & Li, T. (2025) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00353.2024 · Cited by 3
Fibroblast growth factor 19 meets mammalian target of rapamycin: A mitogenic Tête‐à‐Tête under consideration
Krones, E., & Wagner, M. (2016) · Hepatology · doi:10.1002/hep.28691 · Cited by 3
An Atlas of Inter-Organ Metabolite Trafficking in Health and Atherogenic ConditionsPreprint
Bae, H., Jung, S., Le, J., Tamburini, I. J., Kim, J., Wang, E., Song, W.-S., Jang, K.-H., Kang, T., Lopez, M. L., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4869929 · Cited by 3
Fibroblast growth factor 15 overexpression and combined peroxisome proliferator–activated receptor α activation attenuates metabolic dysfunction–associated steatohepatitis progression in mice
Shi, H. Q., Stofan, M., Kong, B., Taylor, R. E., Henry, Z. R., Maliha, S., Rizzolo, D., & Guo, G. L. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100128 · Cited by 2
Integrating bile acid metabolism into precision nutrition strategies for improved swine performance
Li, S., He, Y., Shaoyong, W., Wang, Y., & Jin, M. (2025) · Animal nutrition · doi:10.1016/j.aninu.2025.05.013 · Cited by 2
Interorgan crosstalk in metabolic dysfunction-associated steatotic liver disease
Yang, R., Fang, Z., He, F., & Wang, L. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003927 · Cited by 2
Secondary bile acids impact hepatic energy metabolism in rainbow trout, Oncorhynchus mykiss
Pérez-Tierra, G., Calo, J., Comesaña, S., Velasco, C., Soengas, J. L., & Blanco, A. M. (2026) · Journal of Experimental Biology · doi:10.1242/jeb.251201 · Cited by 2
Intestinal GATA4 deficiency induces proximal fibroblast growth factor 15 expression and represses hepatic gluconeogenesis
Patankar, J. V., Sachdev, V., Obrowsky, S., Levak‐Frank, S., & Kratky, D. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.003 · Cited by 2
Quantification of serum fibroblast growth factor-19 concentration in healthy dogs before and after feeding
Myers, J., Granger, L., Keeton, S., Liu, C., & Johnston, A. N. (2021) · American Journal of Veterinary Research · doi:10.2460/ajvr.82.8.676 · Cited by 3
Neprilysin deficiency reduces hepatic gluconeogenesis in high fat-fed mice
Esser, N., Mongovin, S. M., Mundinger, T. O., Barrow, B. M., & Zraika, S. (2023) · Peptides · doi:10.1016/j.peptides.2023.171076 · Cited by 2
Cross‐sectional and Mendelian randomization study of fibroblast growth factor 19 reveals causal associations with metabolic diseases
Li, Y., Dai, C., Yang, H., Zeng, H., Ruan, Y., Dai, M., Hao, J., Wang, L., Yan, X., & Ji, F. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16687 · Cited by 2
Non-classical hormones from the fibroblast growth factor family
Gronskaia, S., Rusyaeva, N. V., Belaya, Z. E., & Mel'nichenko, G. A. (2024) · Problems of Endocrinology · doi:10.14341/probl13441 · Cited by 2
High-Fat Diet Differentially Regulates Fibroblast Growth Factor Expression in Metabolic Tissues of Young and Aged Male Mice
Lin, Q., Hui, X., Gu, C., Min, K., Xiong, L., Zhou, W., Xu, J. J., Watson, S. E., Wintergerst, K. A., Cai, L., et al. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf096 · Cited by 2
The role of fibroblast growth factors in cell and cancer metabolism
Price, J., & Francavilla, C. (2025) · FEBS Letters · doi:10.1002/1873-3468.70199 · Cited by 3
Biliary Jejunostomy Might Improve Glucose in Type 2 Diabetes Patients
Zhang, N., Chen, W., Yin, H., Liu, W., & He, X. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04319-z · Cited by 2
Bile Acids and Their Receptors
Claudel, T., & Trauner, M. (2009) · Springer eBooks · doi:10.1007/978-3-642-00150-5_21 · Cited by 2
Use of Combination Statin and Bile Acid Sequestrant Therapy to Treat Dyslipidemia
Toth, P. P., Nikolić, D., Rizz, M., Rysz, J., & Banach, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-20433-8_1 · Cited by 2
Upregulation of hypothalamic POMC neurons after biliary diversion in GK rats
Zhou, S., Chen, W., Bai, X., Chen, J., Xu, Q., Dong, L., Chen, W., Qu, Q., & He, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.999928 · Cited by 2
A Polymorphism in the FGF21 Gene is a Novel Risk Variant for Metabolic-Associated Steatohepatitis
Elsayed, A. (2020) · The Sydney eScholarship Repository (The University of Sydney) · Cited by 2
Caffeine improves diethylnitrosamine-induced hepatocellular carcinoma by inhibiting cAMP/PKA/CREB signaling in rats
Shan, L., Wang, C., Fang, X., Zhang, Z., Dai, S., & Liu, J. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102297 · Cited by 1
Unravelling genetic susceptibility and causal factors in liver health using MRI quantification of inflammation, fat and iron in the liver
Meena, D., Pansini, M., Fichera, A., Huang, J., Ahmed, A., Dehghan, A., Banerjee, R., & Yaghootkar, H. (2026) · Human Genomics · doi:10.1186/s40246-026-00913-2 · Cited by 3
Pediococcus pentosaceus JNL0053 Mitigates DSS-induced Colitis in Mice Via the IL-22–Gut Barrier Pathway
Liu, S., Zhang, H., Jin, C., Geng, X., Li, R., Wu, N., & Wang, Y. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11011-z · Cited by 1
Site-specific bidirectional regulation of Fgf15 transcription in the mouse ileum
Katafuchi, T., Honda, A., & Makishima, M. (2026) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00026.2026 · Cited by 1
Persistent activation of growth hormone contributes to sexual dimorphic expression of hepatic drug metabolizing enzymes in Fgf15 transgenic mice
Dai, M., Shi, H., Basaly, V., Meadows, V., Kong, B., & Guo, G. L. (2026) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2026.100368 · Cited by 1
Bile Acids and Bile Flow
Setchell, K. D. R., & Kohli, R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00002-1 · Cited by 1
Familial Intrahepatic Cholestasis
Grammatikopoulos, T. (2021) · Springer eBooks · doi:10.1007/978-3-030-80068-0_61 · Cited by 1
Growth factors reviews
Li, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15793-6.00001-9 · Cited by 1
Integrated metabolomic and transcriptome analyses reveal the regulatory mechanisms of partridge tea phenolics-rich extracts on type 2 diabetes mice
Fan, R., Li, S., Wei, Y., Liu, Y.-X., & Wang, L. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250219 · Cited by 1
Impact of Sleeve Gastrectomy on Body Weight and Food Intake Regulation in Diet-Induced Obese Mice
Balbo, S. L., Soares, G. M., Morari, J., Felisberto, A. M., Vettorazzi, J. F., Bronczek, G. A., Bonfleur, M. L., Carneiro, E. M., Boschero, A. C., & Velloso, L. A. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46110749 · Cited by 1
Familial Intrahepatic Cholestasis
Grammatikopoulos, T., & Thompson, R. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-17169-2_58 · Cited by 1
Mechanistic Target of Rapamycin
McKee-Muir, O. C., & Russell, R. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812146-7.00009-3 · Cited by 2
Gastric Bypass: Mechanisms of Functioning
le Roux, C. W., & Sinclair, P. (2020) · Springer eBooks · doi:10.1007/978-3-030-28803-7_2 · Cited by 1
Metabolic Health with Obesity: A Novel Role for Cholesteryl Ester Transfer Protein
Cappel, D. A. (2014) · Cited by 1
Bile acids and their receptors
Claudel, T., & Trauner, M. A. (2015) · doi:10.1002/9781118663387.ch28 · Cited by 1
Sleeve Gastrectomy Reduces Body Weight and Food Intake in Diet-Induced Obese Mice with No Alterations in Anorexigenic and Orexigenic Hypothalamic GenesPreprint
Balbo, S. L., Soares, G. M., Morari, J., Felisberto, A. M., Vettorazzi, J. F., Bronczek, G. A., Bonfleur, M. L., Carneiro, E. M., Velloso, L. A., & Boschero, A. C. (2024) · Preprints.org · doi:10.20944/preprints202408.2148.v1 · Cited by 1
Roles of ABCG5 ABCG8 cholesterol transporter in lipid homeostasis
Wang, Y. (2015) · UKnowledge (University of Kentucky)
Nuclear receptor regulation of bile acid and nutrient metabolism: 51st Annual Max Miller Lecture in Diabetes Research presented by David Mangelsdorf, PhD
Felice, D. L., & Unterman, T. G. (2012) · Translational research · doi:10.1016/j.trsl.2012.06.002
Bile acid receptors as targets for drug
Schaap, G., Trauner, M. A., & Jansen, P. L. M. (2013)
Efeito da cirurgia bariátrica sobre parâmetros clínicos, laboratoriais e fatores de risco cardiovascular
de Cardiologia, P., & Paulo, S. (2016)
Molecular Nutrition Study of the Transcriptional Regulation of Anti-obesity Hormones
Shimizu, M. (2016) · Nippon Eiyo Shokuryo Gakkaishi · doi:10.4327/jsnfs.69.277
Factors Regulating Features of Metabolic Syndrome
Pijut, S. S. (2017) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2017.044
Surgical management of diabetes mellitus: future outlook
Sazhin, A. V., Khusyainova, A. I., & Petukhov, V. A. (2017) · Endoscopic Surgery · doi:10.17116/endoskop201723146-55
Influence of Age and Frailty on Intestinal and Hepatic Bile Acid Transport in Male C57BL/6 Mice
Gao, T. (2017) · DalSpace (Dalhousie University)
Bile Acids and FGF19 in the Remission of Type 2 Diabetes After Sleeve Gastrectomy and Gastric Bypass
Nemati, R. (2017) · Tuwhera (Auckland University of Technology)
Gastrointestinal Hormones and the Control of Food Intake and Energy Metabolism
PAGE, L. C., Miller, M. D., D’Alessio, D. D., & Tong, J. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-68192-4_3
Acute Regulation of Postprandial Lipemia and Chylomicron Production by Glucagon-Like Peptide-1 and Bile Acid Signaling
Farr, S. (2017) · TSpace (University of Toronto)
Investigations of 12α-Hydroxylated Bile Acid Signaling in Intestinal Organoids
Ahmad, T. R. (2019) · doi:10.7916/d8-gv4d-bm97
Intestinal-derived FGF15 preserves muscle and bone mass following sleeve gastrectomyPreprint
Bozadjieva-Kramer, N., Shin, J. H., Shao, Y., Gutiérrez‐Aguilar, R., Li, Z., Heppner, K. M., Chiang, S., Vargo, S. G., Granger, K., Sandoval, D. A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.02.130278
Metabolic and Electrophysiological Effects of Fibroblast Growth Factor 19 in the Dorsal Vagal Complex
Wean, J. (2021) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2021.383
Faculty Opinions recommendation of Targeting FXR and FGF19 to Treat Metabolic Diseases-Lessons Learned From Bariatric Surgery.
Aguilar-Salinas, C. A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733866855.793558330
Fibrosis induced by chronic cholestatic diseases
Muriel, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99764-5.00005-6
Expression Regulation and Bioactivity of Fibroblast Growth Factor 19/15
白, 玉. (2022) · Pharmacy Information · doi:10.12677/pi.2022.113020
Aging and Chronic Kidney Disease Viewed from the FGF-Klotho Endocrine System
Kuro‐o, M. (2022) · Springer eBooks · doi:10.1007/978-981-16-7977-3_14
Genome-resolved metagenomics of milk microbiomes reveals the influence of maternal dietary fiber on neonatal inheritance of immunoregulatory traitsPreprint
Dennis, P. G., Hoelzle, R. D., Rashid, R. B., Sikder, M. A. A., Lyons, R., Stark, T., & Phipps, S. (2023) · Research Square · doi:10.21203/rs.3.rs-2641343/v1
Effect of Estradiol on Carbohydrate-Fat Metabolism and FGF21 System Activity in Female C57BL/6 Mice with Short-Term Consumption of the Cafeteria Diet
Jakovleva, T., Kazantseva, A., Mamontova, K. Y., & Bazhan, N. (2024) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093024020315
Bile Acids and Gestational Diabetes Mellitus: Exploring the Link and ImplicationsPreprint
Lu, C., Gao, Z., & Lei, X. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4869474
Effect of Estradiol on Carbohydrate-Fat Metabolism and FGF21 System Activity in Female C57BL/6 Mice with Short-Term Consumption of the Cafeteria Diet
Jakovleva, T., Kazantseva, A. Y., Mamontova, K. Y., & Бажан, Н. М. (2024) · Российский физиологический журнал им И М Сеченова · doi:10.31857/s0869813924040054

Authors: Potthoff, M. J., Boney-Montoya, J., Choi, M., He, T., Sunny, N. E., Satapati, S., Suino-Powell, K., Xu, H. E., Gerard, R. D., Finck, B. N., Burgess, S. C., Mangelsdorf, D. J., & Kliewer, S. A.
Affiliations: Howard Hughes Medical Institute (US)
The University of Texas Southwestern Medical Center (US)
Van Andel Institute (US)
Washington University in St. Louis (US)
Corresponding author: Mangelsdorf, David J.
Kliewer, Steven A.
ORCID: Potthoff, Matthew J.
Choi, Mihwa
Sunny, Nishanth E.
Satapati, Santhosh
Xu, H. Eric
Finck, Brian N.
Burgess, Shawn C.
Mangelsdorf, David J.
Kliewer, Steven A.
Venue: Cell Metabolism
Publisher: Elsevier BV
Published: 2011-06
Volume: 13
Issue: 6
Pages: 729-738
ISSN: 1550-4131 (ISSN-L)
DOI: 10.1016/j.cmet.2011.03.019
PMC: PMC3131185
OpenAlex: W2020515276
Cited by: 431
References: 51
Citations by year: 2026: 24 · 2025: 28 · 2024: 34 · 2023: 28 · 2022: 47 · 2021: 39 · 2020: 30 · 2019: 25 · 2018: 22 · 2017: 34 · 2016: 18 · 2015: 28 · 2014: 22 · 2013: 20 · 2012: 24
FWCI: 9.34
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 777 d)
doi.org/10.15223/policy-017 (stm-asf)
doi.org/10.15223/policy-037 (stm-asf)
doi.org/10.15223/policy-012 (stm-asf)
doi.org/10.15223/policy-029 (stm-asf)
doi.org/10.15223/policy-004 (stm-asf)
Locations: Cell Metabolism (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (DK067158, DK076269, DK078184, DK078187, U19DK62434)
Howard Hughes Medical Institute
Welch Foundation (I-1275, I-1588)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Keywords: FGF15/19, hepatic gluconeogenesis, CREB, PGC-1α, hepatic glucose metabolism, carbohydrate homeostasis, bile acids, insulin, transcriptional regulation, dephosphorylation
MeSH terms: Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Animals, Citric Acid Cycle, Fatty Acids, Fibroblast Growth Factors, Gluconeogenesis, Glucose, Liver, Luciferases, Male, Mice, Inbred C57BL, Oxidation-Reduction, Transcription Factors, Signal Transduction, Trans-Activators, Gene Expression, Cyclic AMP Response Element-Binding Protein, Genes, Reporter, Mice, Knockout, Gene Expression Profiling, Mice, Metabolic Networks and Pathways

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

FGF15/19 Regulates Hepatic Glucose Metabolism by Inhibiting the CREB-PGC-1α Pathway

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks